| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.28B | 126.77B | 118.15B | 117.07B | 103.86B | 97.78B |
| Gross Profit | 21.72B | 21.43B | 20.59B | 20.23B | 16.79B | 12.73B |
| EBITDA | 11.72B | 13.23B | 12.97B | 12.77B | 10.20B | 7.62B |
| Net Income | 3.44B | 3.62B | 5.08B | 3.26B | 1.15B | 1.84B |
Balance Sheet | ||||||
| Total Assets | 165.24B | 185.39B | 165.44B | 159.19B | 150.57B | 146.91B |
| Cash, Cash Equivalents and Short-Term Investments | 3.15B | 3.51B | 4.27B | 3.37B | 2.83B | 3.60B |
| Total Debt | 56.87B | 72.27B | 61.88B | 56.34B | 59.14B | 57.68B |
| Total Liabilities | 100.22B | 115.73B | 102.04B | 99.92B | 97.69B | 93.74B |
| Stockholders Equity | 59.27B | 63.33B | 57.73B | 54.17B | 48.24B | 48.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.05B | -5.04B | 3.56B | -3.04B | 5.27B |
| Operating Cash Flow | 0.00 | 9.17B | 8.43B | 9.67B | 4.89B | 11.75B |
| Investing Cash Flow | 0.00 | -16.91B | -12.74B | -5.79B | -6.52B | -4.24B |
| Financing Cash Flow | 0.00 | 6.99B | 5.41B | -3.33B | 843.00M | -6.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥224.36B | 4.69 | 12.70% | 1.68% | 10.76% | 37.39% | |
72 Outperform | ¥7.63B | 7.03 | ― | 0.47% | 1.93% | 1.91% | |
65 Neutral | ¥19.16B | -109.80 | ― | 1.33% | 1.27% | 539.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥43.71B | 14.50 | ― | 2.17% | 2.15% | 45.62% | |
59 Neutral | ¥19.21B | 9.88 | ― | 0.81% | 2.49% | 19.48% | |
58 Neutral | ¥40.31B | 11.78 | ― | 2.58% | 7.30% | -28.80% |